Gedea Biotech reports results from placebo-controlled clinical trial of pHyph, an antibiotic-free treatment for bacterial vaginosis
Uppdated 2022-11-14 - Symptom reduction was seen in 90% of patients and absence of symptoms was noted in 70% of patients - Clinical cure rate was 50,4% in the pHyph group, which is in line with many antibiotic treatments on the market - The rate of recurrence of BV was substantially lower at day 35…
